Login / Signup

Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review.

Julia Richmond DiBelloValerie T RazianoXinyue LiuAmy PuenpatomKathryn PeeblesNazleen F KhanDeanna D Hill
Published in: Infectious diseases and therapy (2024)
In this SLR study, treatment with MOV was effective in reducing the risk of severe outcomes from COVID-19 caused by Omicron variants, especially for older individuals. Differences in the ages and baseline comorbidities of the MOV-treated and control groups may have led to underestimation of the effectiveness of MOV in many observational studies. Real-world studies published to date thus provide additional evidence supporting the continued benefits of MOV in non-hospitalized adults with COVID-19.
Keyphrases
  • coronavirus disease
  • sars cov
  • randomized controlled trial
  • systematic review
  • physical activity
  • early onset
  • copy number
  • community dwelling
  • genome wide